Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for The Unaudited Financial Results For The Quarter Ended 30Th June, 2021

 KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve We wish to inform you that the meeting of the Board of Directors of the Company will be held on Friday, 13th August, 2021 at the Corporate Office of the Company at Mumbai at 12.30 P.M.: 1. To Consider and approve the Standalone and Consolidated Un-audited Financial Result of the Company for the quarter ended 30th June, 2021; 2. Any other matter with the permission of the Chair.
05-08-2021
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Reply To The Clarification Sought On Price Movement Of The Shares Of The Company

 With reference to clarification sought by your good office, we wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. Therefore, the movement in the share price of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such movement in price.
26-07-2021
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Please find enclosed Press Release titled 'Kilitch Drugs starts production of Cephalosporins Injectables at Ethiopia Plant' dated 26th July 2021.
26-07-2021
Bigul

Kilitch Drugs India Ltd - 524500 - Clarification sought from Kilitch Drugs India Ltd

 The Exchange has sought clarification from Kilitch Drugs India Ltd on July 26, 2021 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
26-07-2021
Bigul

Kilitch Drugs India Ltd - 524500 - Disclosure Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015 - Commencement Of Commercial Production

 This is to inform that our green field project in Ethiopia under the name Kilitch Estro Biotech PLC, a foreign subsidiary of the Company at Oromia Special Zone, Ethiopia, has started commercial production of Cephalosporins Injectable line w.e.f 26th July 2021.
26-07-2021
Bigul

Kilitch Drugs India Ltd - 524500 - Shareholding for the Period Ended June 30, 2021

 Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
09-07-2021
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 31st March 2021, in the format specified on the relevant accounting standards.
08-07-2021
Bigul

KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended June 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1010 Name of the Signatory :- Garima TrivediDesignation :- Company Secretary and Compliance Officer
08-07-2021
Bigul

Kilitch Drugs India Ltd - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 We are enclosing herewith certificate issued by the Registrar & Share Transfer Agent M/s. Link Intime India Private Limited confirming the compliance of Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018.
06-07-2021
Bigul

Kilitch Drugs India Ltd - 524500 - Closure of Trading Window

 With reference to the above subject, this is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with NSE Circular Reference no. NSE/CML/2019/11 and BSE Circular Reference no. LIST/COMP/01/2019-20, both dated April 02, 2019 Trading Window for dealing in Securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with effect from Thursday, July 01, 2021 till 48 hours after the declaration of Financial Results of the Company for the quarter ended June 30, 2021. The date of meeting of Board of Directors to approve the Financial Results of the Company for the quarter ended June 30, 2021 will be informed in due course.
30-06-2021
Next Page
Close

Let's Open Free Demat Account